Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hammerness

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Journal of Affective Disorders|June 19, 2007
Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescentsPaul Hammerness, Theresa Harpold, Carter Petty, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 19, 2016
A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescentsSusan E Sprich, Steven A Safren, Daniel Finkelstein, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|June 21, 2024
Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from MexicoAngel Rios Medina, Paul Hammerness, Demvihin Ihyembe, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric Mick, Craig Surman, et al.
European Child & Adolescent Psychiatry|April 21, 2009
Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label studyPaul Hammerness, Robert Doyle, Meghan Kotarski, et al.
The Journal of Nervous and Mental Disease|July 17, 2007
Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHDTheresa Harpold, Joseph Biederman, Martin Gignac, et al.
Biological Psychiatry|October 22, 2005
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age childrenJoseph Biederman, Eric Mick, Paul Hammerness, et al.
Journal of Attention Disorders|July 13, 2005
Reexamining the familial association between asthma and ADHD in girlsPaul Hammerness, Michael C Monuteaux, Stephen V Faraone, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 24, 2008
The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their familiesMichael C Monuteaux, Stephen V Faraone, Paul Hammerness, et al.
CNS Neuroscience & Therapeutics|January 15, 2010
Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week studyCraig Surman, Paul Hammerness, Carter Petty, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Affective Disorders|June 19, 2007
Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescentsPaul Hammerness, Theresa Harpold, Carter Petty, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 19, 2016
A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescentsSusan E Sprich, Steven A Safren, Daniel Finkelstein, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|June 21, 2024
Complex ADHD Challenging Case: Managing Co-Occurring Attention-Deficit Hyperactivity Disorder and Congenital Heart Disease with a Limited Medication Formulary: A Case from MexicoAngel Rios Medina, Paul Hammerness, Demvihin Ihyembe, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric Mick, Craig Surman, et al.
European Child & Adolescent Psychiatry|April 21, 2009
Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label studyPaul Hammerness, Robert Doyle, Meghan Kotarski, et al.
The Journal of Nervous and Mental Disease|July 17, 2007
Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHDTheresa Harpold, Joseph Biederman, Martin Gignac, et al.
Biological Psychiatry|October 22, 2005
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age childrenJoseph Biederman, Eric Mick, Paul Hammerness, et al.
Journal of Attention Disorders|July 13, 2005
Reexamining the familial association between asthma and ADHD in girlsPaul Hammerness, Michael C Monuteaux, Stephen V Faraone, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 24, 2008
The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their familiesMichael C Monuteaux, Stephen V Faraone, Paul Hammerness, et al.
CNS Neuroscience & Therapeutics|January 15, 2010
Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week studyCraig Surman, Paul Hammerness, Carter Petty, et al.
Pageof 7